Searched for
COVID 19 DIAGNOSTICS
Avience Biomedicals IPO: Check GMP, price band and other detailsThe grey market premium (GMP) for the issue stood at 36% ahead of the opening, implying an unofficial market price of around Rs 283 against...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 27%As the market seems to be in comeback mode, it helps to be aware that the best (and probably biggest) wealth creator of the last couple of ...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsThere are market phases when one risk dominates. Then there are phases like this, when risks arrive from every direction and refuse to stan...
- What to know about the outbreak of a rare kind of Ebola as cases outpace responseA rare Ebola outbreak is spreading rapidly in Congo and Uganda. The Bundibugyo virus has no approved treatments. Health workers face challe...
- India sends emergency medical supplies for Ebola outbreak response in CongoIndia has provided crucial pharmaceutical supplies to aid the fight against the Ebola outbreak in Congo. The Africa Centres for Disease Con...
- What happens when investors stop SIPs during crises–real investors, real panic, and the real cost of walking awayFrom a cancer diagnosis in Kolkata to a layoff in Bengaluru to Covid panic in Agra—real investors, real crises, and the real cost of walkin...
- Long-term Investing: Ecosystem with an edge called India; 12 large- mid- and small-cap stocks with upside potential of up to 34%Tactical investing should not be confused with long-term investing. In a world where geopolitical risk, commodity shocks, and uncertainty a...
- Vikas Khemani-backed Q-Line Biotech IPO subscribed over 2 times on Day 1 as GMP soars to 42%Vikas Khemani-backed Q-Line Biotech's IPO opened on Wednesday, aiming to raise up to Rs 214.48 crore on NSE Emerge. The company, operating ...
- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 25%Here’s a thing investors in equity need to keep in mind. A large part of the upmove one might see in the next one or two trading sessions w...
- In 1983, Kary Mullis imagined copying DNA while driving through California at night: the idea transformed modern genetics foreverWhile cruising through the scenic highways of California, a visionary scientist named Kary Mullis stumbled upon an extraordinary concept th...
- Fake life-saving medicine racket busted in Delhi: Here's how they repackaged and sold drugs across several statesDelhi Police crime branch busted an interstate counterfeit medicine racket, arresting four individuals. The network allegedly sourced gover...
- India faces no immediate public health threat from hantavirus: NIV chiefTwo Indian nationals aboard a cruise ship have reportedly contracted hantavirus. Indian health officials assure the public that these cases...
- India among 8 nations seeking 5-year patent waiver for Covid diagnosticsIn a submission to the World Trade Organization, they said that diagnostics and therapeutics are "essential tools for a comprehensive appro...
- WTO Council defers decision on TRIPS waiver extension"In view of paragraph 8 of the ministerial decision on the TRIPS Agreement adopted on June 17, 2022 providing that no later than six months...
- India wants 5-year IPR waiver on Covid tests, treatmentsAt a meeting of the Trade-related Aspects of Intellectual Property Rights (TRIPS) Council on Tuesday, India and others submitted a text pro...
- US delays patent waiver deal for Covid diagnostics, therapeuticsThe 12th Ministerial Conference decision of the World Trade Organization (WTO) contains a commitment that no later than six months from the...
- TCS deploys blockchain-based system to speed up Covid-19 diagnostic test-kit productionAs a technology partner to C-CAMP, TCS has developed and deployed a digital supply-chain platform to manage the MSME ecosystem, based on it...
- India plans to double testing capacity through new project: C-CAMPThe Rockefeller Foundation has provided financial support for the project executed by the Bangalore Life Science Cluster, which would impro...
- Covid-19 test kit Corosure developed by IIT Delhi launched; base price at Rs 399With the launch, the RT-PCR based Covid-19 diagnostic kit will now be available for use by the authorised testing labs. Even after adding t...
- Private labs may soon be allowed to test for coronavirus infectionRoche has also received a licence from the Indian drug regulator for a specific SARS-Covid-19 diagnostic that can test thousands of samples...
Load More
